Trials / Unknown
UnknownNCT03441607
Safety & Efficacy FloGraft (Micronized Human Amnion Chorion Membrane)® in Adults With Pain Due to OA of the Knee
Safety & Efficacy of Micronized Human Amnion Chorion Membrane Biologic (mHACMb) FloGraft (Micronized Human Amnion Chorion Membrane)® in Adults With Pain Due to Osteoarthritis of the Knee
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 320 (estimated)
- Sponsor
- Applied Biologics, LLC · Industry
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
Safety \& Efficacy of FloGraft (Micronized Human Amnion Chorion Membrane)® in Adults With Pain Due to Osteoarthritis of the Knee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mHACMb | Active ingredient |
| OTHER | placebo | inactive ingredient |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2019-02-01
- Completion
- 2019-03-01
- First posted
- 2018-02-22
- Last updated
- 2018-09-28
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03441607. Inclusion in this directory is not an endorsement.